When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CYDY - CytoDyn: Recent Data Warrants A Change In Game Plan
CytoDyn Inc
CytoDyn recently reported preliminary analysis from Leronlimab in mTNBC patients and NASH. I believe this data supports further development of Leronlimab in NASH and cancer indications.
The recent data has provided me enough confidence to change my strategy. I am looking to start allocating some of my shares for a long-term position at these levels.
I discuss why I am changing my approach to CYDY, as well as my "ditch list."